Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
A-Ching ChaoTsong-Hai LeeLuther C PettigrewYousef HannawiHung-Yu HuangNai-Fang ChiLung ChanPo-Lin ChenThomas DevlinPublished in: Drug design, development and therapy (2024)
Clinicaltrials.gov identifier: NCT04091945.